← FDA DRUG APPROVALS

FDA ANDA · ANDA062803

CLEOCIN PHOSPHATE

Sponsor: PFIZER

APPLICATION
ANDA062803
TYPE
ANDA
ORIGINAL APPROVAL
1987-10-16
LATEST ACTION
2017-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CLEOCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

2017-09-11Labeling · Supplement 35 · standardAP
2016-08-18Labeling · Supplement 27 · standardAP
2016-08-18Labeling · Supplement 25 · standardAP
2016-08-18Labeling · Supplement 31 · standardAP
2016-08-18Labeling · Supplement 26 · standardAP
2016-08-18Labeling · Supplement 32 · standardAP
2000-04-05Manufacturing (CMC) · Supplement 12AP
1998-10-01Labeling · Supplement 11AP
1998-01-12Labeling · Supplement 6AP
1996-04-30Labeling · Supplement 4AP
1996-02-02Manufacturing (CMC) · Supplement 10AP
1993-09-23Labeling · Supplement 8AP
1992-10-30Manufacturing (CMC) · Supplement 9AP
1992-07-06Manufacturing (CMC) · Supplement 5AP
1990-03-22Manufacturing (CMC) · Supplement 3AP
1987-10-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →